BioXcel Therapeutics (BTAI) Market Cap (2018 - 2026)
BioXcel Therapeutics (BTAI) market cap from Mar 8, 2018 to Jun 12, 2026. The current BioXcel Therapeutics (BTAI) market cap is $31M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
BioXcel Therapeutics (BTAI) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +14.58% |
| 3 Years TTM | -78.05% |
| 5 Years TTM | -66.30% |
| All Time TTM | -39.83% |
Annual Market Cap change of BioXcel Therapeutics (BTAI)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $31M | -13.60% |
| 2025 | $36M | +92.51% |
| 2024 | $19M | -96.03% |
| 2023 | $468M | -86.27% |
| 2022 | $3.41B | +5.66% |
| 2021 | $3.22B | -56.00% |
| 2020 | $7.32B | +216.22% |
| 2019 | $2.32B | +278.50% |
| 2018 | $612M | N/A |
Comparison BioXcel Therapeutics (BTAI) market cap with competitors
BioXcel Therapeutics (BTAI) market cap is $30.87M.